Pharmaron pays $118.7 million for AbbVie UK biomanufacturing site
This transaction complements Pharmaron’s recent acquisition of Absorption Systems in the US for building an integrated cell and gene therapy services platform
China-based Pharmaron, an R&D service provider for the life sciences industry, has agreed to buy AbbVie's Allergan Biologics manufacturing plant in Liverpool, UK, for US$118.7 million in cash.
The move comes nine months after AbbVie closed its $63 billion buyout of Allergan, which saw the Big Pharma firm diversify its drug portfolio beyond its best-selling blockbuster product, Humira.
In a statement, Pharmaron said the transaction, which is expected to close in the second quarter of 2021, would be "highly synergistic" to its recent acquisition of Absorption Systems in the US for building an integrated cell and gene therapy services platform.
This integrated platform offers preclinical research, product development, and commercial manufacturing services for cell and gene therapy products.
The Liverpool site has held an MHRA biologic manufacturing license accreditation since 2007 and consists of a flexible cGMP biomanufacturing facility with more than 150 staff.
Leveraging the expertise in process R&D, cGMP manufacturing and advanced analytical capabilities in a broad range of biologics products, the Allergan site has further established a solid foundation and know-how in cell and gene therapy product development using a suspension system for manufacturing up to commercial scale.
"The addition ... will further strengthen our cell and gene therapy services platform and allow us to better serve our partners’ needs in these exciting and emerging therapies.," said Dr Boliang Lou, Chairman and CEO of Pharmaron. "We are committed to further expanding capabilities and capacities at the Liverpool site to meet growing unmet demand."
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance